Spyros Papapetropoulos - 04 Jun 2025 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Director
Signature
/s/ Spyros Papapetropoulos
Issuer symbol
LPCN
Transactions as of
04 Jun 2025
Net transactions value
+$5,645
Form type
4
Filing time
05 Jun 2025, 16:06:40 UTC
Previous filing
18 Apr 2025
Next filing
02 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Papapetropoulos Spyros Director 675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY /s/ Spyros Papapetropoulos 05 Jun 2025 0001832694

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Stock Option (Right to Buy) Award $5,645 +1,764 +33% $3.20 7,174 04 Jun 2025 Common Stock 1,764 $3.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% vesting one year from date of grant.